News tagged with chronic myeloid leukemia
Second-line CML drugs evoke faster response than front-line therapy
Dec 07, 2009 |
not rated yet |
0
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University ...
Drug shows promise for T315I-mutated chronic myeloid leukemia
Dec 07, 2009 |
not rated yet |
0
Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. ...
FDA approved leukemia drugs shows promise in ovarian cancer cells
Nov 10, 2009 |
not rated yet |
0
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, ...
Finding key to cancer drug Gleevec's limitations
Aug 05, 2009 |
not rated yet |
1
University of Michigan researchers have developed an animal model that provides strong evidence why imatinib, marketed as Gleevec, helps patients with chronic myeloid leukemia survive longer, but does not ...
Stem cell protein offers a new cancer target
Jun 01, 2009 |
not rated yet |
0
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
Therapeutic effect of imatinib improved with addition of chloroquine
Apr 13, 2009 |
not rated yet |
0
The therapeutic effects of the blockbuster leukemia drug imatinib may be enhanced when given along with a drug that inhibits a cell process called autophagy, researchers from the Kimmel Cancer Center at Jefferson reported ...
